通过激活AMPK通路,MEGF9可以防止脂聚糖诱导的心脏功能障碍
Zhili Jin1,2, Xianqing Li1,2, Huixia Liu1,2
1Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China.
Redox report : communications in free radical research
|December 31, 2024
概括
多重EGF类域9 (MEGF9) 通过减少炎症和氧化损伤,保护免受败血症引起的心脏功能障碍. MEGF9激活AMP激活蛋白激酶 (AMPK) 途径,为败血症提供治疗点.
科学领域:
- 心血管研究研究心血管研究
- 分子生物学分子生物学
- 败血症的发病原因
背景情况:
- 败血症引起的心脏功能障碍包括炎症和氧化损伤.
- 多重EGF类域9 (MEGF9) 在败血症相关心脏损伤中的作用尚不清楚.
研究的目的:
- 研究MEGF9在败血症引起的心脏损伤中的作用和机制.
- 探索MEGF9作为毒症的潜在治疗点.
主要方法:
- 在体外和体内使用病毒载体操纵MEGF9表达.
- 脂聚糖 (LPS) 用于诱导心肌细胞和小鼠的败血损伤.
- 使用全球AMPK淘汰赛小鼠研究AMP激活蛋白激酶 (AMPK) 途径.
主要成果:
- 在心肌细胞和小鼠中,LPS刺激降低了MEGF9的表达.
- 低血MEGF9水平与败血症患者的心脏功能障碍相关.
- MEGF9过度表达减轻了LPS诱导的炎症和心脏损伤,而敲击则使其恶化.
- 通过激活AMPK通路,MEGF9可以缓解心脏功能障碍.
结论:
- MEGF9可以防止LPS诱导的炎症,氧化损伤和心脏损伤.
- 对AMPK通路的MEGF9激活对于其保护作用至关重要.
- 向MEGF9为败血症引起的心脏功能障碍提供了潜在的治疗策略.
更多相关视频
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
289
09:16Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
7.2K
相关概念视频
cAMP-dependent Protein Kinase Pathways
6.0K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.0K
MAPK Signaling Cascades
4.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
4.9K
